Thyroid Eye Disease: Updates on Comprehensive Management (CME Symposium at NANOS 2024)

Honolulu, HI US
March 4, 2024 to March 5, 2024

Monday, March 4, 2024
5:45 PM – 6:15 PM HST Complimentary Registration and Dinner
6:15 PM – 7:15 PM HST CME Symposium

Sheraton Waikiki Beach Resort

Moloki Room, 2nd Level
2255 Kalakaua Avenue
Honolulu, Hawaii

This symposium is not organized by NANOS. We are sharing this information as this can be of value to the NANOS annual meeting attendees and membership.

Target Audience

This educational activity is intended for neuro-ophthalmologists and other ophthalmologists treating thyroid eye disease.

Learning Objectives

After completing this activity, participants will be better able to:

  • Identify diagnostic criteria that are critical for identifying patients with thyroid eye disease
  • Develop individualized treatment plans for patients with thyroid eye disease according to the latest clinical data
  • Review strategies to manage hyperglycemia and hearing loss in patients with thyroid eye disease receiving insulin-like growth factor 1 receptor antagonists
  • Recognize the roles and responsibilities of the multidisciplinary care team in thyroid eye disease management
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Course opens: 
Course expires: 
Event starts: 
03/04/2024 - 11:15pm EST
Event ends: 
03/05/2024 - 12:15am EST
Sheraton Waikiki Beach Resort
2255 Kalakaua Avenue
Molokai Room, 2nd Level
Honolulu, HI 96815
United States
+1 (888) 236-2427


Andrew G. Lee, MD (Co-Chair)
Herb and Jean Lyman Centennial Chair in Ophthalmology
Department of Ophthalmology
Blanton Eye Institute
Professor of Ophthalmology, Neurology, and Neurosurgery
Academic Institute
Full Clinical Member
Research Institute
Houston Methodist
Weill Cornell Medical College
Houston, Texas
Prem S. Subramanian, MD, PhD (Co-Chair)
Chief, Neuro-Ophthalmology
Clifford R. and Janice N. Merrill Endowed Chair in Ophthalmology
Vice Chair for Academic Affairs, Ophthalmology
Professor in Ophthalmology, Neurology, and Neurosurgery
Sue Anschutz-Rodgers University of Colorado Eye Center
University of Colorado School of Medicine
Aurora, Colorado

Disclosure Policy

MedEdicus adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers, or others, are required to disclose all financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been identified and mitigated by MedEdicus prior to the commencement of the activity.


Andrew G. Lee, MD, is a consultant for Alexion Pharmaceuticals, Inc, AstraZeneca, Bristol-Myers Squibb, Stoke Therapeutics, and Viridian Therapeutics, Inc; and is on the speakers bureau for Amgen Inc.

Prem S. Subramanian, MD, PhD, is a consultant for Acelyrin, Inc; is an advisory board member of Amgen Inc, GenSight Biologics, Kriya Therapeutics, and Viridian Therapeutics, Inc; and is a contracted researcher for Immunovant, Inc, Invex Therapeutics*, Neurophth Therapeutics, and Tourmaline Bio, Inc.

Peer Reviewer

Hadi Kaakour, MD, MS, was an advisory board member of Alimera Sciences*.

Planners, Managers, and Writers

MedEdicus planners, managers, and writers have no relevant commercial relationships to disclose.

* The financial relationship existed during the past 24 months but has now ended

Accreditation Statement

 MedEdicus LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement

MedEdicus LLC designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Commercial Support

This continuing medical education activity is supported through an educational grant from Amgen Inc.

Off-Label Discussion

This educational activity may include discussion of unlabeled and/or investigational uses of drugs and devices. Please refer to the official prescribing information for each drug or device discussed in this activity for approved dosing, indications, and warnings.

Americans With Disabilities Act

MedEdicus fully complies with the legal requirements of the ADA and the rules and regulations thereof. Please contact with any special needs (eg, physical, dietary) prior to the program.

Provider Contact Information

For questions about this educational activity, please contact MedEdicus LLC at

Fee Information

There is no fee for this educational activity.


The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of MedEdicus LLC or Amgen Inc.

This CME activity is copyrighted to MedEdicus LLC ©2024. All rights reserved. 314

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Please login or register to take this course.

Follow these steps to obtain your CME credit for this activity:

Step 1. Login or Register for a complimentary MedEdicus Learning Portal account

Step 2. Click the purple Take Course button to proceed to the online evaluation

Step 3. Complete the evaluation and the certificate will be made available immediately to download/print